Validation of "Clinical evaluation methods for new antibacterial drugs to treat respiratory infections" (second version)
Not Applicable
- Conditions
- Community-acquired bacterial pneumonia
- Registration Number
- JPRN-UMIN000004831
- Lead Sponsor
- agasaki evaluation organization for clinical interventions
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with bronchial obstruction or those who have a past history of obstructive pneumonia (excluding COPD patients). 2) Patients with primary lung cancer or those who have pulmonary metastasis. 3) Patients with cystic fibrosis, AIDS, pneumocystis pneumonia (including suspected pneumocystis pneumonia), or active pulmonary tuberculosis (including suspected active pulmonary tuberculosis). 4) Patients with suspected atypical pneumonia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical response at the test-of-cure (TOC) visit.
- Secondary Outcome Measures
Name Time Method